JP Morgan Chase’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $9.16K | Buy |
5,485
+5,443
| +12,960% | +$8.96K | ﹤0.01% | 6763 |
|
|
2025
Q4 | $73 | Sell |
42
-65,164
| -100% | -$144K | ﹤0.01% | 7237 |
|
|
2025
Q3 | $153K | Buy |
65,206
+61,516
| +1,667% | +$118K | ﹤0.01% | 5663 |
|
|
2025
Q2 | $7.51K | Sell |
3,690
-13,941
| -79% | -$26.7K | ﹤0.01% | 6361 |
|
|
2025
Q1 | $28.7K | Buy |
17,631
+5,687
| +48% | +$11.4K | ﹤0.01% | 6041 |
|
|
2024
Q4 | $21.9K | Buy |
11,944
+190
| +2% | +$841 | ﹤0.01% | 6234 |
|
|
2024
Q3 | $67.9K | Buy |
11,754
+458
| +4% | +$3.78K | ﹤0.01% | 5873 |
|
|
2024
Q2 | $91.3K | Buy |
11,296
+10,823
| +2,288% | +$114K | ﹤0.01% | 5562 |
|
|
2024
Q1 | $6.57K | Sell |
473
-652
| -58% | -$5.63K | ﹤0.01% | 6401 |
|
|
2023
Q4 | $6.88K | Sell |
1,125
-4,055
| -78% | -$20K | ﹤0.01% | 6497 |
|
|
2023
Q3 | $24.2K | Sell |
5,180
-246,360
| -98% | -$1.36M | ﹤0.01% | 6022 |
|
|
2023
Q2 | $1.35M | Sell |
251,540
-21,299
| -8% | -$172K | ﹤0.01% | 3828 |
|
|
2023
Q1 | $2.68M | Sell |
272,839
-243
| -0.1% | -$4.14K | ﹤0.01% | 3328 |
|
|
2022
Q4 | $5.11M | Sell |
273,082
-1,775
| -0.6% | -$40.2K | ﹤0.01% | 2794 |
|
|
2022
Q3 | $5.69M | Sell |
274,857
-11,431
| -4% | -$293K | ﹤0.01% | 2632 |
|
|
2022
Q2 | $5.94M | Sell |
286,288
-447
| -0.2% | -$12.6K | ﹤0.01% | 2636 |
|
|
2022
Q1 | $12.4M | Sell |
286,735
-29,755
| -9% | -$1.34M | ﹤0.01% | 2166 |
|
|
2021
Q4 | $19M | Sell |
316,490
-25,828
| -8% | -$2.07M | ﹤0.01% | 1874 |
|
|
2021
Q3 | $29.4M | Buy |
342,318
+55,897
| +20% | +$5.61M | ﹤0.01% | 1483 |
|
|
2021
Q2 | $31.9M | Buy |
286,421
+154,790
| +118% | +$14.9M | ﹤0.01% | 1470 |
|
|
2021
Q1 | $14.7M | Buy |
131,631
+40,244
| +44% | +$5.29M | ﹤0.01% | 2007 |
|
|
2020
Q4 | $9.71M | Buy |
91,387
+38,991
| +74% | +$5.19M | ﹤0.01% | 2245 |
|
|
2020
Q3 | $7.11M | Buy |
52,396
+2,581
| +5% | +$538K | ﹤0.01% | 2297 |
|
|
2020
Q2 | $16.1M | Buy |
49,815
+12,723
| +34% | +$2.04M | ﹤0.01% | 1526 |
|
|
2020
Q1 | $3.31M | Buy |
37,092
+22,922
| +162% | +$1.41M | ﹤0.01% | 2587 |
|
|
2019
Q4 | $561K | Sell |
14,170
-23,452
| -62% | -$706K | ﹤0.01% | 4177 |
|
|
2019
Q3 | $925K | Buy |
37,622
+2,254
| +6% | +$68.5K | ﹤0.01% | 3877 |
|
|
2019
Q2 | $1.24M | Buy |
35,368
+32,917
| +1,343% | +$1.31M | ﹤0.01% | 3711 |
|
|
2019
Q1 | $110K | Buy |
2,451
+73
| +3% | +$3.68K | ﹤0.01% | 4853 |
|
|
2018
Q4 | $114K | Buy |
2,378
+231
| +11% | +$14K | ﹤0.01% | 4798 |
|
|
2018
Q3 | $143K | Buy |
2,147
+744
| +53% | +$41.4K | ﹤0.01% | 4817 |
|
|
2018
Q2 | $66K | Sell |
1,403
-340
| -20% | -$18.8K | ﹤0.01% | 4974 |
|
|
2018
Q1 | $98K | Sell |
1,743
-44
| -2% | -$2.38K | ﹤0.01% | 4595 |
|
|
2017
Q4 | $89K | Buy |
1,787
+1,513
| +552% | +$93.8K | ﹤0.01% | 4705 |
|
|
2017
Q3 | $21K | Buy |
274
+34
| +14% | +$2.53K | ﹤0.01% | 4628 |
|
|
2017
Q2 | $23K | Buy |
240
+29
| +14% | +$2.48K | ﹤0.01% | 4511 |
|
|
2017
Q1 | $16K | Buy |
211
+3
| +1% | +$239 | ﹤0.01% | 4739 |
|
|
2016
Q4 | $18K | Buy |
208
+151
| +265% | +$13.7K | ﹤0.01% | 4720 |
|
|
2016
Q3 | $6K | Sell |
57
-535
| -90% | -$59.1K | ﹤0.01% | 4348 |
|
|
2016
Q2 | $66K | Sell |
592
-532
| -47% | -$64.6K | ﹤0.01% | 3979 |
|
|
2016
Q1 | $118K | Buy |
1,124
+154
| +16% | +$11.9K | ﹤0.01% | 3725 |
|
|
2015
Q4 | $78K | Sell |
970
-2,038
| -68% | -$162K | ﹤0.01% | 3829 |
|
|
2015
Q3 | $209K | Buy |
3,008
+61
| +2% | +$5.32K | ﹤0.01% | 3672 |
|
|
2015
Q2 | $289K | Buy |
2,947
+1,580
| +116% | +$169K | ﹤0.01% | 3729 |
|
|
2015
Q1 | $134K | Buy |
1,367
+213
| +18% | +$20.6K | ﹤0.01% | 3885 |
|
|
2014
Q4 | $127K | Hold |
1,154
| – | – | ﹤0.01% | 4081 |
|
|
2014
Q3 | $136K | Buy |
+1,154
| New | +$144K | ﹤0.01% | 4059 |
|
|
2013
Q3 | – | Sell |
-3,167
| Closed | -$121K | – | 4415 |
|
|
2013
Q2 | $121K | Buy |
+3,167
| New | +$96K | ﹤0.01% | 4119 |
|
Other funds holding INO
VCM
BCM
ACM
EP
